Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38

X Bai, D Ma, A Liu, X Shen, QJ Wang, Y Liu, Y Jiang - Science, 2007 - science.org
X Bai, D Ma, A Liu, X Shen, QJ Wang, Y Liu, Y Jiang
Science, 2007science.org
The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is
regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to
growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR
through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally
related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that
of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its …
The mammalian target of rapamycin, mTOR, is a central regulator of cell growth. Its activity is regulated by Rheb, a Ras-like small guanosine triphosphatase (GTPase), in response to growth factor stimulation and nutrient availability. We show that Rheb regulates mTOR through FKBP38, a member of the FK506-binding protein (FKBP) family that is structurally related to FKBP12. FKBP38 binds to mTOR and inhibits its activity in a manner similar to that of the FKBP12-rapamycin complex. Rheb interacts directly with FKBP38 and prevents its association with mTOR in a guanosine 5′-triphosphate (GTP)–dependent manner. Our findings suggest that FKBP38 is an endogenous inhibitor of mTOR, whose inhibitory activity is antagonized by Rheb in response to growth factor stimulation and nutrient availability.
AAAS